Identification and Characterization of Carbohydrate-Based Adjuvants

Area of Science:

• Immunology
• Carbohydrate Chemistry
• Vaccinology

Background:

• Modern vaccines (recombinant proteins, nucleic acids) are safe but often lack immunogenicity, necessitating effective adjuvants.
• Carbohydrates show promise as adjuvants by targeting dendritic cells and modulating immune responses.
• C-type lectin receptors (CLRs), expressed on innate immune cells, are key targets for immune modulation.

Purpose of the Study:

• To develop a protocol for identifying novel carbohydrate ligands for C-type lectin receptors (CLRs).
• To conjugate identified carbohydrate CLR ligands to a model antigen (ovalbumin).
• To evaluate the immunomodulatory potential of these novel glycoconjugates in vitro and in vivo.

Main Methods:

• Utilized glycan arrays with recombinant CLR-Fc chimeras to identify carbohydrate CLR ligands.
• Employed covalent conjugation techniques to link identified ligands to ovalbumin (OVA).
• Assessed T cell activation in vitro and immunomodulation in vivo using the developed glycoconjugates.

Main Results:

• Successfully identified novel carbohydrate ligands capable of binding to CLRs.
• Developed a method for creating antigen-carbohydrate conjugates.
• Demonstrated the potential of these glycoconjugates to modulate T cell responses.

Conclusions:

• Carbohydrates are effective CLR ligands and can serve as potent vaccine adjuvants.
• The described protocol facilitates the discovery and application of novel carbohydrate-based immunomodulators.
• This approach offers a promising strategy for enhancing vaccine efficacy and safety.